Role of Fas ligand in conferring immune privilege to non-lymphoid cells

被引:6
|
作者
Guller, S
机构
[1] NYU MED CTR, DEPT OBSTET & GYNECOL, NEW YORK, NY 10016 USA
[2] NYU MED CTR, DEPT BIOCHEM, NEW YORK, NY 10016 USA
来源
关键词
D O I
10.1111/j.1749-6632.1997.tb48547.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:268 / 272
页数:5
相关论文
共 50 条
  • [11] Immune privilege or inflammation? Insights into the Fas ligand enigma
    O'Connell, J
    Houston, A
    Bennett, MW
    O'Sullivan, G
    Shanahan, F
    NATURE MEDICINE, 2001, 7 (03) : 271 - 274
  • [12] B cells in non-lymphoid tissues
    Samiea, Abrar
    Celis, George
    Yadav, Rashi
    Rodda, Lauren B.
    Moreau, Joshua M.
    NATURE REVIEWS IMMUNOLOGY, 2025,
  • [13] The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces
    Guller, S
    LaChapelle, L
    SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1999, 17 (01): : 39 - 44
  • [14] RECEPTORS FOR IMMUNE-COMPLEXES ON CELLS WITHIN A NON-LYMPHOID MURINE TUMOR
    BRASLAWSKY, GR
    YAACKUBOWICZ, M
    FRENSDORFF, A
    WITZ, IP
    JOURNAL OF IMMUNOLOGY, 1976, 116 (06): : 1571 - 1578
  • [15] Fas/Fas-ligand interactions modulate immune privilege and immune deviation in the eye.
    Ferguson, TA
    Herndon, JM
    Griffith, TS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 5202 - 5202
  • [16] Activation-induced cell death: The controversial role of Fas and Fas ligand in immune privilege and tumour counterattack
    Maher, S
    Toomey, D
    Condron, C
    Bouchier-Hayes, D
    IMMUNOLOGY AND CELL BIOLOGY, 2002, 80 (02): : 131 - 137
  • [18] FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE
    GRIFFITH, TS
    BRUNNER, T
    FLETCHER, SM
    GREEN, DR
    FERGUSON, TA
    SCIENCE, 1995, 270 (5239) : 1189 - 1192
  • [19] ANGIOGENESIS INDUCTION BY XENOGENEIC LYMPHOID AND NON-LYMPHOID CELLS IN MICE
    KAMINSKI, MJ
    BEM, W
    MAJEWSKI, S
    KAMINSKA, G
    SZMURLO, A
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 1981, 29 (04) : 521 - 523
  • [20] Fas ligand is a mediator of relative immune privilege in non-specialised peripheral tissue in inflammation
    Dooldeniya, MD
    Dupont, PJ
    Ambrose, LR
    Lechler, RI
    Simpson, E
    Dyson, PJ
    Warrens, AN
    IMMUNOLOGY, 2005, 116 : 44 - 44